Cargando…
Metformin and Risk of Malignant Brain Tumors in Patients with Type 2 Diabetes Mellitus
The risk of malignant brain tumors associated with metformin use has rarely been investigated in humans. This retrospective cohort study investigated such an association. Patients with new-onset type 2 diabetes mellitus diagnosed from 1999 to 2005 in the nationwide database of Taiwan’s national heal...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391370/ https://www.ncbi.nlm.nih.gov/pubmed/34439890 http://dx.doi.org/10.3390/biom11081226 |